SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-000602
Filing Date
2024-01-03
Accepted
2024-01-03 09:15:42
Documents
12
Period of Report
2024-01-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm241724d1_8k.htm   iXBRL 8-K 27459
  Complete submission text file 0001104659-24-000602.txt   204302

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aplt-20240103.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20240103_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20240103_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT tm241724d1_8k_htm.xml XML 3386
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 24504522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)